Literature DB >> 22093597

Sudden cardiac arrest and sudden cardiac death on dialysis: Epidemiology, evaluation, treatment, and prevention.

Martin A Alpert1.   

Abstract

Sudden cardiac death is the most common cause of death in dialysis patients and is usually preceded by sudden cardiac arrest due to ventricular tachycardia or ventricular fibrillation. A variety of risk factors have been identified that predispose the sudden cardiac arrest and sudden cardiac death in dialysis patients. Primary prevention of sudden cardiac arrest in dialysis patients may be accomplished by avoiding the use of low potassium dialysate. Pharmacotherapy with beta-blockers angiotensin converting enzyme inhibitors and angiotensin receptor blockers and use of implantable cardioverter defibrillators (ICDs) may also prevent sudden cardiac arrest and sudden cardiac death in high-risk dialysis patients. Secondary prevention of sudden cardiac death may be accomplished by similar pharmacotherapy and by the use of ICDs. Indications for ICD use in dialysis patients are similar to those for nondialysis patients; however, survival rates following ICD implantation in dialysis patients are substantially lower than in non-dialysis patients. 2011 The Author; Hemodialysis International. 2011 International Society for Hemodialysis.

Entities:  

Mesh:

Year:  2011        PMID: 22093597     DOI: 10.1111/j.1542-4758.2011.00598.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  6 in total

1.  Near-term prediction of sudden cardiac death in older hemodialysis patients using electronic health records.

Authors:  Benjamin A Goldstein; Tara I Chang; Aya A Mitani; Themistocles L Assimes; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

2.  αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats.

Authors:  Paulo Giovani de Albuquerque Suassuna; Paula Marocolo Cherem; Bárbara Bruna de Castro; Edgar Maquigussa; Marco Antonio Cenedeze; Júlio Cesar Moraes Lovisi; Melani Ribeiro Custódio; Helady Sanders-Pinheiro; Rogério Baumgratz de Paula
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-17

3.  The assessment of P-wave dispersion and myocardial repolarization parameters in patients with chronic kidney disease.

Authors:  Korhan Kollu; Lutfullah Altintepe; Cevdet Duran; Mustafa Topal; Samil Ecirli
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

4.  Clinical Associations between Serial Electrocardiography Measurements and Sudden Cardiac Death in Patients with End-Stage Renal Disease Undergoing Hemodialysis.

Authors:  Hyun Jin Lee; A Reum Choe; HaeJu Lee; Dong Ryeol Ryu; Ea Wha Kang; Jung Tak Park; Su Hwan Lee; Junbeom Park
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

5.  Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.

Authors:  Chao-Hsiun Tang; Chia-Chen Wang; Tso-Hsiao Chen; Chuang-Ye Hong; Yuh-Mou Sue
Journal:  J Am Heart Assoc       Date:  2016-01-06       Impact factor: 5.501

Review 6.  Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle.

Authors:  Paulo G de Albuquerque Suassuna; Helady Sanders-Pinheiro; Rogério B de Paula
Journal:  Front Med (Lausanne)       Date:  2018-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.